Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis ; volume:22 ; number:1 ; day:14 ; month:8 ; year:2020 ; pages:1-9 ; date:12.2020
Arthritis Research & Therapy ; 22, Heft 1 (14.8.2020), 1-9, 12.2020
- Creator
-
Smolen, Josef S.
Kang, Young Mo
Yoo, Wan-Hee
Emery, Paul
Weinblatt, Michael E.
Keystone, Edward C.
Genovese, Mark C.
Myung, Gihyun
Baek, Inyoung
Ghil, Jeehoon
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-020-02267-z
- URN
-
urn:nbn:de:101:1-2020100721463497060538
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Smolen, Josef S.
- Kang, Young Mo
- Yoo, Wan-Hee
- Emery, Paul
- Weinblatt, Michael E.
- Keystone, Edward C.
- Genovese, Mark C.
- Myung, Gihyun
- Baek, Inyoung
- Ghil, Jeehoon
- SpringerLink (Online service)
Other Objects (12)
Can baseline serum microRNAs predict response to TNF-alpha inhibitors in rheumatoid arthritis?
Baseline bony erosions and time-averaged DAS28 predict discontinuation of TNF inhibitors in rheumatoid arthritis
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
Matrix Metalloproteinases-3 Baseline Serum Levels in Early Rheumatoid Arthritis Patients without Initial Radiographic Changes: A Two-Year Ultrasonographic Study
Real-Life Tolerability and Effectiveness of Adalimumab Biosimilar in Rheumatoid Arthritis: ASPIRE Registry Data
Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis
Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF
Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment
Assessing the risk of rapid radiographic progression in Hungarian rheumatoid arthritis patients
High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
Can baseline serum microRNAs predict response to TNF-alpha inhibitors in rheumatoid arthritis?
Baseline bony erosions and time-averaged DAS28 predict discontinuation of TNF inhibitors in rheumatoid arthritis
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
Matrix Metalloproteinases-3 Baseline Serum Levels in Early Rheumatoid Arthritis Patients without Initial Radiographic Changes: A Two-Year Ultrasonographic Study
Real-Life Tolerability and Effectiveness of Adalimumab Biosimilar in Rheumatoid Arthritis: ASPIRE Registry Data
Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis
Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF
Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment
Assessing the risk of rapid radiographic progression in Hungarian rheumatoid arthritis patients
High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study
Biosimilar-to-Biosimilar Switching: What is the Rationale and Current Experience?
Can baseline serum microRNAs predict response to TNF-alpha inhibitors in rheumatoid arthritis?
Baseline bony erosions and time-averaged DAS28 predict discontinuation of TNF inhibitors in rheumatoid arthritis
Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis
Review of Biosimilar Trials and Data on Etanercept in Rheumatoid Arthritis
Matrix Metalloproteinases-3 Baseline Serum Levels in Early Rheumatoid Arthritis Patients without Initial Radiographic Changes: A Two-Year Ultrasonographic Study
Real-Life Tolerability and Effectiveness of Adalimumab Biosimilar in Rheumatoid Arthritis: ASPIRE Registry Data
Independent associations of anti-cyclic citrullinated peptide antibodies and rheumatoid factor with radiographic severity of rheumatoid arthritis
Circulating TNF-like protein 1A (TL1A) is elevated early in rheumatoid arthritis and depends on TNF
Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment
Assessing the risk of rapid radiographic progression in Hungarian rheumatoid arthritis patients
High titers of both rheumatoid factor and anti-CCP antibodies at baseline in patients with rheumatoid arthritis are associated with increased circulating baseline TNF level, low drug levels, and reduced clinical responses: a post hoc analysis of the RISING study